Resolution: standard / high
Figure 5.
Prospectively identified Case 3: Tumor from initial presentation classified as a mucinous
borderline ovarian tumor (BOT) and shows a discrete area of HER2 positivity in what
is predominantly a HER2 negative tumor.
McAlpine et al. BMC Cancer 2009 9:433 doi:10.1186/1471-2407-9-433
Download authors' original image